Research at Berlin-Buch
The Berlin-Buch Campus is a unique site for medical research and development in Germany. The Max Delbrück Center for Molecular Medicine (MDC), founded in 1992 as a model for clinical research from three institutes of the GDR Academy of Sciences, was the initial driving force for the development of the campus into a research and biotechnology site of supraregional significance. Since 2000, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has played a major role in this development.
Today, on the 32-hectare site which can look back on a long scientific tradition, institutes for basic medical research, research clinics and biotechnology companies are located in close proximity to each other. Buch's researchers, doctors and entrepreneurs are collaborating in the development of new treatments and diagnostic procedures for cancer, cardiovascular and nervous system diseases.
A modern Congress Center with integrated laboratories on the campus offers multiple opportunities for scientific interaction.
News research
The path of new immunotherapies to the clinic
Bringing a new CAR‑T cell therapy from promising results in the lab to critically ill cancer patients is anything but straightforward. A Tagesspiegel podcast featuring, among others, Armin Rehm explor...
more ...A single cocaine dose alters mouse brain cells
Researchers led by Ana Pombo have found that just one exposure to the drug can create changes in mouse brain cells that persist for at least two weeks. Their findings were presented at the Federation ...
more ...How the skin distinguishes cool from warm
Researchers in the lab of James Poulet have uncovered how the nervous system senses cool and warm temperatures. The findings, published in “Neuron” challenge a long-standing view of temperature sensi...
more ...Events Campus
01.09.2026, 08:00
Aktualisierungskurs für Projektleiter und Beauftragte für Biologische Sicherheit nach § 28 GenTSV
Ein-Tages-Onlinekurs mit gesetzlich vorgeschriebenen Lehrinhalten, anerkannt und zertifiziert vom Landesamt für Gesundheit und Soziales (LAGeSo)
more ...08.09.2026, 09:00
From Target to Market - The BBA Biotech & Pharma Summer School
The 4-day intensive course provides a comprehensive overview of the entire drug development process in biotechnology and in the pharmaceutical industry – from the idea to the market.
more ...11.09.2026, 18:30
Wie verändert Stammzellforschung die Medizin von morgen? Diabetes, Muskelerkrankungen, Organoide
Könnten Stammzellen eines Tages Menschen mit Diabetes helfen? Welche neuen Perspektiven gibt es bei Muskelerkrankungen? Und warum spielen sogenannte Organoide – kleine Organmodelle aus dem Labor – ein...
more ...
